48,706
edits
(create) |
|||
Line 2: | Line 2: | ||
==Positive== | ==Positive== | ||
*[[Plasma cell]]s. | *[[Plasma cell]]s.<ref name=Ref_WMSP554>{{Ref WMSP|554}}</ref> | ||
*[[Plasma cell neoplasm]]. | *[[Plasma cell neoplasm]]. | ||
*Triple negative breast cancer.<ref name=pmid25273930 >{{Cite journal | last1 = Lim | first1 = GH. | last2 = Tan | first2 = PH. | last3 = Jara-Lazaro | first3 = AR. | last4 = Thike | first4 = AA. | last5 = Sim | first5 = WC. | last6 = Yap | first6 = VB. | last7 = Yip | first7 = GW. | title = Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival. | journal = Singapore Med J | volume = 55 | issue = 9 | pages = 468-72 | month = Sep | year = 2014 | doi = | PMID = 25273930 }} | *Triple negative breast cancer.<ref name=pmid25273930 >{{Cite journal | last1 = Lim | first1 = GH. | last2 = Tan | first2 = PH. | last3 = Jara-Lazaro | first3 = AR. | last4 = Thike | first4 = AA. | last5 = Sim | first5 = WC. | last6 = Yap | first6 = VB. | last7 = Yip | first7 = GW. | title = Syndecan-1 is a potential biomarker for triple-positive breast carcinomas in Asian women with correlation to survival. | journal = Singapore Med J | volume = 55 | issue = 9 | pages = 468-72 | month = Sep | year = 2014 | doi = | PMID = 25273930 }} |
edits